OWCP OWC Pharmaceutical Research Corp.

O-I Glass in Hot Water Over Misleading Statements I'll tell you, nothing gets my goat quite like uncovering deceptive practices in the corporate world. It seems O-I Glass, Inc. (NYSE: OI), might have played a fast one with its shareholders. The company is staring down the barrel of a class action lawsuit from Schall, Brown & Schwartz LLP, alleging they weren't entirely...

Imagine a world where simply sleeping in cleaner air could affect your blood sugar. Seems far-fetched, I know. But that's where we're at with this new study out of NYU Langone Health. They're talking about using plain ol' portable air filters to help steady blood sugar levels for folks dealing with prediabetes. Turns out a cleaner bedroom might just hold the key to taming...

Riding the Roller Coaster of Financials Crack open the books, and there's more than meets the eye with ADC Therapeutics this quarter. We're talking a $21 million haul in product revenue—that's nothing to sneeze at. Things are heating up with their balance sheet, thanks to a strategic restructuring that's stretching their cash runway out to 2029. That’s some...

Revolutionizing Stroke Care: Enter Evategrel When it comes to strokes, time is money—and I'm telling you, this ain't an area where you can afford to twiddle your thumbs. The faster you can get that blood flowing again, the better the chance you've got of walking away with less damage. That's where CureGene's new investigational drug, Evategrel, comes in. Why Evategrel...

Big Shoes, Bigger Expectations Who's steering the Goodyear ship now that Mark Stewart's out the door? Roger Wood's the name, interim CEO is the game. Don't fret too much—the board's hustling to nail down a permanent top dog. But this isn't a musical chairs game; it's a full-on strategic shift. Goodyear's forming committees, juggling ideas, and ripping through their...

Wuliangye Takes Center Stage at Global Event Everyone's chasing that global branding magic, but here's Wuliangye strutting its stuff at the Global Panda Partners Conference. Held in Sichuan Province from November 2 to 4, this is not just another show; it's a bold move from the Chinese baijiu maker to push the 'harmony and coexistence' mantra on the world stage. Not just...

Soluna's Upcoming Earnings Call: A Crucial Update Here we are again, folks—floating on the edge of another one of Soluna Holdings' earnings calls. Mark November 16, 2026, on your calendar because that's when Soluna's slated to drop its third quarter financials and walk us through the numbers. At 5:00 PM Eastern Time, they're firing up the webcast and phone lines for a...

Rosti Bets on Expansion with Alvi Buyout Rosti Group just rolled the dice big by swallowing Alvi Group, marking another bold move in the ever-swinging industrial and medical device manufacturing rodeo. Suddenly, we’re talking about a company with roughly 3,000 employees on its roster and a neat EUR 450 million in combined revenue. Don't overlook the power play...

Innovent's Latest Breakthrough with SINTBILO® One moment you're sipping coffee, the next you're staring at a clinical milestone. Innovent Biologics has shouted from the rooftops that their drug, SINTBILO® (tafolecimab injection), has wrapped up its Phase 3 CREDIT-5 study, snagging the primary endpoint with both hands. This isn't just any drug; it's marked as the first...

Paul Taubman Steers the Ship at CSHL Here's the buzz coming out of Cold Spring Harbor Lab: they're handing the reins over to Paul Taubman. It's like swapping captains in the middle of the ocean—big shoes need to stay afloat. This place isn't just the playground for science nerds; it's a powerhouse in biomedical research. Now, we've got Taubman, a fella who's been...

Breaking Down Barriers in Robotics Vision Forget the robots of old; today’s machines need eyes sharper than a hawk just to keep up with the competition. Advantech (TWSE: 2395) isn’t just watching—they’re leading the pack with their GMSL Camera Enablement Scheme. They’re accelerating robotics from Autonomous Mobile Robots (AMRs) to humanoids, and it’s about...

Exploring New Beginnings at the Hopedale Gold Project The excitement in the mining sector continues to grow as Labrador Gold Corp. (TSX-V: LAB | OTCQB: NKOSF | Frankfurt: 2N6) embarks on its 2025 exploration journey at the Hopedale Gold Project. With a dedicated field crew now mobilized, the company is ready to explore this promising gold-rich terrain located within the...

OTCQB Venture Virtual Investor Conference Overview The OTCQB Venture Virtual Investor Conference is set to take place on August 7, offering a unique platform for investors to engage with innovative companies. Who Should Attend? This event is open to individual investors, institutional investors, advisors, and financial analysts eager to explore emerging opportunities....

DAiM's Bold Step into the Future with Fetch.ai DAiM, a pioneering crypto wealth management firm located in Florida, is thrilled to share its new strategic investment in Fetch.ai, a standout project that merges artificial intelligence (AI) with blockchain technology. This innovative combination is aimed at streamlining data sharing and automating various processes, thereby...

Atlantic American Corporation Stock Hits a New Low In a tough market, Atlantic American Corporation (AAME) has recently hit a 52-week low, with its stock priced at $1.43 USD. This notable decline highlights a period of bearish sentiment for the insurance holding company, which has seen its share value drop by 17.18% over the past year. Investors are closely watching the...